Navigation Links
Delcath Signs First Partner Agreement in Asia
Date:2/9/2010

esire to bring innovative technology to the Taiwan medical community, to expand our current product offerings in the oncology segment, and lastly and most importantly, to support the government healthcare system efforts to potentially reduce the death rate and improve the quality of life for hepatic cancer patients. We further see this as the first step in building a strong partnership with Delcath as their platform technology is adapted to treat new cancers and other disease indications in the future." 

About Delcath Systems, Inc.

Delcath Systems, Inc. is a medical device company specializing in cancer treatment. The Company is testing a proprietary, patented drug delivery system for the treatment of primary and metastatic liver cancers. Delcath's novel drug delivery platform is testing the delivery of ultra-high doses of anti-cancer drugs to the liver while preventing these high doses of drug from entering the patient's bloodstream.  Delcath is currently conducting a Phase III clinical trial and multi-arm Phase II clinical trial of the Delcath PHP System with melphalan in patients with liver cancers. The Company maintains a broad intellectual property portfolio on a worldwide basis including the U.S., Europe, Asia and Canada. For more information, please visit the Company's website at www.delcath.com.

About Chi-Fu Trading Co., Ltd. 

Chi-Fu is a private company that has been serving the medical community in Taiwan since 1930.  As an importer and distributor of medical devices, medical equipment, pharmaceuticals, cons
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... DALLAS , July 24, 2014 /PRNewswire-iReach/ -- ... days once order is placed. Photo ... is a professional and in-depth market survey on ... firstly reviews the basic information of Hemodialysis Machine ... report then explores global and China,s top manufacturers ...
(Date:7/24/2014)... Cancer patients in the west of ... closer to home when a new radiotherapy center opens near ... (NYSE: VAR ) has been selected to equip ... for four TrueBeam™ medical linear accelerators. Two ... radiotherapy and radiosurgery treatments, will replace older treatment machines at ...
(Date:7/24/2014)...  Blueprint Medicines (Blueprint), a leader in discovering highly ... announced the appointment of Jeffrey Albers as ... Algeta ASA, where he served on the executive management ... Bayer. Mr. Albers succeeds Alexis Borisy , co-founder ... Rock Ventures, who will remain an active member of ...
Breaking Medicine Technology:Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 2Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 3Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer 2
... ATLANTA, May 30, 2012 Advanced automation, sophisticated eScribe ... portal are among the new innovations showcased in Elekta,s ... of Clinical Oncology (ASCO) Annual Meeting, June 1-4, at ... for the sixth consecutive year, Elekta (booth #4019) ...
... 30, 2012  Actavis Group, an international generic pharmaceuticals ... approval of Nifedipine Extended-Release Tablets, USP, 90mg, a ... the product has commenced.  Nifedipine ... $23 million for the 12 months ending December ...
Cached Medicine Technology:Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting 2Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting 3Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP) 2
(Date:7/24/2014)... all prenatal ultrasounds uncover antenatal hydronephrosis, or enlarged ... the United States. Many children with this abnormality ... first few years of life with the hopes ... Until recently, however, little evidence existed as to ... cost and inconvenience for families. But a study ...
(Date:7/24/2014)... The North American air and missile defense radar ... is expected to register a CAGR of 8.22% to reach ... market for the air and missile defense radar system. However, ... budget cuts as well. , Browse through the TOC of ... to get an idea of the in-depth analysis provided. This ...
(Date:7/24/2014)... Aristotle said, "Love is composed of a single soul ... you and your partner were made in heaven for ... study. , Psychologists observe that people talk and ... such diversity are some common themes that frame how ... considers love as perfect unity ("made for each other," ...
(Date:7/24/2014)... Washington, DC (PRWEB) July 24, 2014 ... pleased to announce the launch of a new version ... Interview Scheduling Manager, or PRISM, for applicants participating in ... PRISM permits applicants to track and organize program information ... summaries in advance of creating their rank order lists. ...
(Date:7/24/2014)... DC (PRWEB) July 24, 2014 ... problem of prescription non-adherence at Cardinal Health RBC ... 26th. Utilizing familiar and user-friendly Mobile devices, RxNetwork ... and payers. , Already embraced by over ... motivating patients and caregivers through timely alerts and ...
Breaking Medicine News(10 mins):Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 3Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 2Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 3Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 4Health News:New research: When it hurts to think we were made for each other 2Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 2Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 3Health News:RxNetwork Brings the Next Generation Customer Care Connectivity to Pharmacies, Providers, and Patients 2
... adults are being diagnosed with type 2 diabetes and now ... greater risk for a heart attack and stroke. //Specifically, the ... 14-times more likely to suffer a heart attack and 30-times ... diabetes. ,"This means that huge numbers of people are ...
... cancer patients who receive radiation therapy after undergoing ... likely to develop complications.// However, a new study ... ,Researchers from the Fox Chase Cancer Center studied ... mastectomy, breast reconstruction, and postoperative radiation between 1987 ...
... Doctors may have a new tool to help acne patients. ... for acne sufferers. //This is important because this skin disease ... and sometimes even suicide. ,Doctors from London recruited 41 ... patients received one treatment of the pulsed-dye laser. The other ...
... have far more to be concerned about than only their ... kidney disease are in the highest risk group for heart ... also applies to people who are in the very early ... in end-stage renal disease have a greater risk of heart ...
... will put almost anything in their mouths. But as ... they eat,// particularly if they have not tried it ... troublesome.But scientists say thousands of years ago toxins in ... high risk of food poisoning.,So it makes sense that ...
... help ward off obesity as children get older.// ... long-term data available on breastfeeding and weight of ... aimed at clarifying the situation. In both, investigators ... to see how breastfeeding impacts weight. Detailed breastfeeding ...
Cached Medicine News:
... heavy duty, controlled stretch knee support that ... allowing full range of motion. The ... the knee, and help to keep the ... This is an excellent support for ...
... breathable foam. Three piece design for precise ... loop closures. Lightweight rigid posterior stays with ... with optional hot and cold therapy Gel ... pain cycle by providing cold therapy to ...
... Scoring: , One of the outstanding features ... our patented Three-Dimensional Molding Technology. , This ... brace which effectively controls the bunching and ... comfort to the wearer. , ...
... new padding system from Innovation Sports. Exceptionally ... contours to the unique anatomy of each ... Gel Fit's proprietary Octogrip™ Anti-Slip System improves ... when the brace is strapped on. Gel ...
Medicine Products: